NIKI
Niki BioSolutions, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.20
−4.76%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- +51.6%
- EBIT
- +52.1%
- Net income
- +68.1%
- EPS
- +75.6%
- Free cash flow
- -54.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025